Superiority of metronomic chemotherapy compared to conventional mode in elderly people with advanced breast neoplasia

Introduction. Breast cancer is a serious disease with incidence steadily increasing with age. The evolution of its therapeutic management requires new strategies, including oral chemotherapy. Objective. To conduct a study in Eastern Algeria comparing two oral chemotherapy treatment regimens. Mat...

Full description

Bibliographic Details
Published in:	Batna Journal of Medical Sciences
Main Authors:	Amina BOUGUETTAYA, Taha FILALI
Format:	Article
Language:	Arabic
Published:	Algerian Society of Clinical & Oncological Pharmacy 2025-09-01
Subjects:	breast cancer oral chemotherapy classical metronomic grade 3/4 toxicity
Online Access:	https://batnajms.net/wp-content/uploads/Archives/2025/3/BJMS_Bouguettaya.pdf

Similar Items

Metronomic chemotherapy regimens in oncology
by: M. Yu. Fedyanin, et al.
Published: (2016-04-01)

Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
by: Kiran Kumar, et al.
Published: (2020-01-01)

Metronomic palliative chemotherapy in maxillary sinus tumor
by: Vijay M Patil, et al.
Published: (2016-01-01)

Metronomic Chemotherapy - A New Path to Treat Advanced Non-small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2015-04-01)

Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology
by: Gonçalo N. Petrucci, et al.
Published: (2024-06-01)

Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells
by: Yamila Sanchez, et al.
Published: (2024-03-01)

Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives
by: Vijay Kumar Panthi, et al.
Published: (2023-04-01)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
by: Do Young Kim
Published: (2017-06-01)

Efficacy and tolerability of metronomic chemotherapy in patients with metastatic breast cancer – an international experience in West Sweden and in the South of Ireland.
by: Catherine Weadick, et al.
Published: (2020-01-01)

A real-world study of oral low-dose metronomic vinorelbine in elderly patients with metastatic triple-negative breast cancer
by: Jiayin Li, et al.
Published: (2026-04-01)

Metronomic Chemotherapy Combined with Dendritic Cell Vaccine  Inhibits VEGF Secretion
by: Yan ZHOU, et al.
Published: (2013-09-01)

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
by: Min Shi, et al.
Published: (2020-03-01)

Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
by: Longjiang She, et al.
Published: (2022-09-01)

Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy
by: Lin-Feng Guo, et al.
Published: (2025-09-01)

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
by: Xiuwen Guan, et al.
Published: (2020-07-01)

Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
by: Nusrat Jan, et al.
Published: (2024-02-01)

Maintenance metronomic chemotherapy combined with conventional treatment for metastatic breast cancer patients
by: Sherif Elzawawy, et al.
Published: (2015-12-01)

Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma
by: Ke Wu, et al.
Published: (2019-08-01)

Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy
by: Oyku Yagmur Basar, et al.
Published: (2024-05-01)

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
by: Ruby Maharjan, et al.
Published: (2019-07-01)

Metronomic therapy for gynecologic cancers
by: Wen-Hsiang Su, et al.
Published: (2012-06-01)

The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience
by: Tsung-Jang Yeh, et al.
Published: (2021-02-01)

On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach
by: Urszula Ledzewicz, et al.
Published: (2017-01-01)

Metronomic chemotherapy in pediatric neuroblastoma
by: Yi Jiang, et al.
Published: (2024-12-01)

Metronomic Chemotherapy in the Treatment of Infantile Parotid Hemangioma &ndash; A Case Report
by: Dadaboev A, et al.
Published: (2025-09-01)

Dynamics and control of a mathematical model for metronomic chemotherapy
by: Urszula Ledzewicz, et al.
Published: (2015-07-01)

Metronomic therapy with oral 6-mercaptopurine in elderly acute myeloid leukemia: A prospective pilot study
by: Akhil Kapoor, et al.
Published: (2016-01-01)

Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer – efficacy, tolerability and quality of life results from the phase II METRO trial
by: Karolina Larsson, F, et al.
Published: (2024-12-01)

Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study
by: Jiaxuan Liu, et al.
Published: (2025-01-01)

Bilateral CMV Retinitis in a Patient with Relapsed Non-Hodgkin Lymphoma on Oral Metronomic Chemotherapy: Case Report and Review of Literature
by: Fen Saj, et al.
Published: (2025-02-01)

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study
by: F. F. Pepe, et al.
Published: (2022-09-01)

A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer
by: Yue Chai, et al.
Published: (2023-08-01)

Comparison between hematological and biochemical changes caused by conventional and metronomic chemotherapies in the treatment of canine transmissible venereal tumor
by: Paulo H. Braz, et al.
Published: (2021-04-01)

An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
by: Vijay M Patil, et al.
Published: (2016-01-01)

Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma
by: Amira Elwan, et al.
Published: (2025-01-01)

Assessment of metronomic chemotherapy–induced DNA damage in peripheral blood leukocytes from canine mammary cancer patients using the alkaline comet assay
by: Lorena Elizabeth Chalco–Torres, et al.
Published: (2024-01-01)

Efficacy and Toxicity of Metronomic Oral Vinorelbinen in Advanced Non-small Cell Lung Cancer after Failure to Multiple-lines Treatments
by: Shuyang YAO, et al.
Published: (2017-11-01)

The Relationship of Ludwig Van Beethoven and Johann Nepomuk Mälzel Through the Metronome
by: Göknil Özkök Sezener
Published: (2024-12-01)

Metastatic primary angiosarcoma of the breast: Can we tame it the metronomic way
by: Raja Pramanik, et al.
Published: (2017-01-01)

Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathway
by: Marta Banchi, et al.
Published: (2025-04-01)